First Republic Executives Fail in Attempt to Recover Nonqualified Deferred Compensation Plan Assets
Myriad is facing yet another challenge to its remaining BRCA gene testing franchise, this time from Quest Diagnostics joined by its R&D arm, Nichols Institute. Quest is "the world's leading provider of diagnostic information...more